Informa 1H23 Results
Capital Allocation Discipline
Pharma Intelligence (Citeline) for £1.8bn
2022 Divestments
Maritime Intelligence (Lloyd's List) for £377m
Fund Flow Intelligence (EPFR) for £165m
Total value £2.5bn, post-tax cash proceeds of c.£1.9bn,
plus ongoing equity interests in Pharma and Maritime
c£2.5bn
Divestment Value
2023 Half-Year Results
c28x
Avg EV/EBITDA multiple
c£200m
Annualised Revenue
April 2023 Tarsus for $940m
May 2023 Winsight for $380m
2023 Acquisitions¹
c£1.2bn¹
July 2023 Canalys
July 2023 HIMSS Global Health Exhibition/Conference¹
Acquisition investment
Effective capital management
informa
Sub-9x
Avg EV/EBITDA multiple
£300m+
Annualised Revenue
¹Informa today announced exclusivity to acquire HIMSS Global 21
Health Exhibition/ConferenceView entire presentation